Status:
COMPLETED
Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer
Lead Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Conditions:
Female Breast Neoplasms
Carcinoma, Ductal, Breast
Eligibility:
FEMALE
18-65 years
Phase:
PHASE3
Brief Summary
Rationale Axillary surgery is still fundamental part of breast cancer (BC) management for adjuvant treatment planning. Purpose Randomized phase III trial to compare the effectiveness of surgical th...
Detailed Description
OBJECTIVES: To compare the efficacy of conservative surgery, with or without axillary lymphnode removal (quadrantectomy with axillary dissection (QUAD) vs. quadrantectomy alone (QU)) followed by adju...
Eligibility Criteria
Inclusion
- women with T1N0M0 invasive breast cancer
- 18-65 years
Exclusion
- bilateral breast cancer
- no other prior or concurrent malignancy except basal cell carcinoma
Key Trial Info
Start Date :
May 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2003
Estimated Enrollment :
565 Patients enrolled
Trial Details
Trial ID
NCT01508546
Start Date
May 1 1998
End Date
May 1 2003
Last Update
January 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy, 20133